Literature DB >> 15128836

Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible.

Katsushi Amano1, Patrick S C Leung, Qingchai Xu, Jan Marik, Chao Quan, Mark J Kurth, Michael H Nantz, Aftab A Ansari, Kit S Lam, Mikio Zeniya, Ross L Coppel, M Eric Gershwin.   

Abstract

Previous work has demonstrated that immunization of rabbits with the xenobiotic 6-bromohexanoate coupled to BSA breaks tolerance and induces autoantibodies to mitochondria in rabbits. Such immunized rabbits develop high-titer Abs to pyruvate dehydrogenase complex (PDC)-E2, the major autoantigen of primary biliary cirrhosis. In efforts to map the fine specificity of these autoantibodies, rabbits were immunized biweekly with 6-bromohexanoate-BSA and screened for reactivity using a unique xenobiotic-peptide-agarose microarray platform with an emphasis on identifying potential structures that mimic the molecular image formed by the association of lipoic acid with the immunodominant PDC-E2 peptide. Essentially, a total of 23 xenobiotics and lipoic acid were coupled to the 12-mer peptide backbones, PDC, a mutant PDC, and albumin. As expected, we succeeded in breaking tolerance using this small organic molecule coupled to BSA. However, unlike multiple experimental methods of breaking tolerance, we report in this study that, following continued immunization, the rabbits recover tolerance. With repeated immunization, the response to the rPDC-E2 protein increased with a gradual reduction in autoantibodies against the lipoic acid-peptide, i.e., the primary tolerance-breaking autoantigen. Detailed analysis of this system may provide strategies on how to restore tolerance in patients with autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128836     DOI: 10.4049/jimmunol.172.10.6444

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.

Authors:  Nicola Bizzaro; Giovanni Covini; Floriano Rosina; Paolo Muratori; Elio Tonutti; Danilo Villalta; Fiorenza Pesente; Maria Grazia Alessio; Marilina Tampoia; Antonio Antico; Stefan Platzgummer; Brunetta Porcelli; Lucia Terzuoli; Marco Liguori; Danila Bassetti; Ignazio Brusca; Piero L Almasio; Giuseppe Tarantino; Chiara Bonaguri; Paolo Agostinis; Elena Bredi; Renato Tozzoli; Pietro Invernizzi; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 2.  Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis.

Authors:  Tin K Mao; Paul A Davis; Joseph A Odin; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

Review 3.  Environmental Basis of Autoimmunity.

Authors:  Annarosa Floreani; Patrick S C Leung; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 4.  Update on primary biliary cirrhosis.

Authors:  Pietro Invernizzi; Carlo Selmi; M Eric Gershwin
Journal:  Dig Liver Dis       Date:  2010-03-31       Impact factor: 4.088

Review 5.  Concept on the pathogenesis and treatment of primary biliary cirrhosis.

Authors:  Vasiliy-Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

6.  Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity.

Authors:  Phornnop Naiyanetr; Jeffrey D Butler; Liping Meng; Janice Pfeiff; Thomas P Kenny; Kathryn G Guggenheim; Roman Reiger; Kit Lam; Mark J Kurth; Aftab A Ansari; Ross L Coppel; Marcos López-Hoyos; M Eric Gershwin; Patrick S C Leung
Journal:  J Autoimmun       Date:  2011-07-18       Impact factor: 7.094

7.  Immune-mediated bile duct injury: The case of primary biliary cirrhosis.

Authors:  Carlo Selmi; Andrea Affronti; Laura Ferrari; Pietro Invernizzi
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

Review 8.  Experimental evidence on the immunopathogenesis of primary biliary cirrhosis.

Authors:  Carlo Selmi; Francesca Meda; Anaid Kasangian; Pietro Invernizzi; Zhigang Tian; Zhexiong Lian; Mauro Podda; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

9.  Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.

Authors:  Kanji Wakabayashi; Zhe-Xiong Lian; Patrick S C Leung; Yuki Moritoki; Koichi Tsuneyama; Mark J Kurth; Kit S Lam; Katsunori Yoshida; Guo-Xiang Yang; Toshifumi Hibi; Aftab A Ansari; William M Ridgway; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

10.  Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.

Authors:  K Wakabayashi; K Yoshida; P S C Leung; Y Moritoki; G-X Yang; K Tsuneyama; Z-X Lian; T Hibi; A A Ansari; L S Wicker; W M Ridgway; R L Coppel; I R Mackay; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2008-12-15       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.